These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 36933287)

  • 1. A new risk score for the assessment of outcomes for Chinese patients with peripartum cardiomyopathy.
    Zhang Z; Zheng W; Chen M; Xie Q; Huang M; Li W; Huang Z
    Heart Lung; 2023; 60():81-86. PubMed ID: 36933287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of Early Diagnosis in Peripartum Cardiomyopathy.
    Lewey J; Levine LD; Elovitz MA; Irizarry OC; Arany Z
    Hypertension; 2020 Jan; 75(1):91-97. PubMed ID: 31707840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting poor left ventricular function recovery in Peripartum cardiomyopathy.
    Prameswari HS; Iswandi CP; Hasan M; Martanto E; Putra ICS; Kamarullah W; Dewi TI; Akbar MR
    J Matern Fetal Neonatal Med; 2023 Dec; 36(2):2279018. PubMed ID: 37935592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence, Risk Factors, Maternal and Neonatal Outcomes of Peripartum Cardiomyopathy (PPCM) in Oman.
    Al Riyami N; Al Khayari S; Al Zadjali R; Machado L; Al Madhani A; Al Lawati H
    Glob Heart; 2023; 18(1):23. PubMed ID: 37153846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripartum women with dyspnea in the emergency department: Is it peripartum cardiomyopathy?
    Wang WW; Wang Y
    Medicine (Baltimore); 2018 Aug; 97(31):e11516. PubMed ID: 30075517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripartum cardiomyopathy in Iraq: initial registry-based data and 6 month outcomes.
    Farhan HA; Yaseen IF
    ESC Heart Fail; 2021 Oct; 8(5):4048-4054. PubMed ID: 34184413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertensive disorders in women with peripartum cardiomyopathy: insights from the ESC EORP PPCM Registry.
    Jackson AM; Petrie MC; Frogoudaki A; Laroche C; Gustafsson F; Ibrahim B; Mebazaa A; Johnson MR; Seferovic PM; Regitz-Zagrosek V; Mbakwem A; Böhm M; Prameswari HS; Fouad DA; Goland S; Damasceno A; Karaye K; Farhan HA; Hamdan R; Maggioni AP; Sliwa K; Bauersachs J; van der Meer P;
    Eur J Heart Fail; 2021 Dec; 23(12):2058-2069. PubMed ID: 34114268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrocardiographic findings in peripartum cardiomyopathy.
    Honigberg MC; Elkayam U; Rajagopalan N; Modi K; Briller JE; Drazner MH; Wells GL; McNamara DM; Givertz MM;
    Clin Cardiol; 2019 May; 42(5):524-529. PubMed ID: 30843220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In peripartum cardiomyopathy plasminogen activator inhibitor-1 is a potential new biomarker with controversial roles.
    Ricke-Hoch M; Hoes MF; Pfeffer TJ; Schlothauer S; Nonhoff J; Haidari S; Bomer N; Scherr M; Stapel B; Stelling E; Kiyan Y; Falk C; Haghikia A; Binah O; Arany Z; Thum T; Bauersachs J; van der Meer P; Hilfiker-Kleiner D
    Cardiovasc Res; 2020 Sep; 116(11):1875-1886. PubMed ID: 31711127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Characteristics and Long-term Predictors of Persistent Left Ventricular Systolic Dysfunction in Peripartum Cardiomyopathy.
    Li W; Li H; Long Y
    Can J Cardiol; 2016 Mar; 32(3):362-8. PubMed ID: 26586094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of NT-proBNP for myocardial recovery in peripartum cardiomyopathy (PPCM).
    Hoevelmann J; Muller E; Azibani F; Kraus S; Cirota J; Briton O; Ntsekhe M; Ntusi NAB; Sliwa K; Viljoen CA
    Clin Res Cardiol; 2021 Aug; 110(8):1259-1269. PubMed ID: 33555408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute kidney injury predicts poor left ventricular function for patients with peripartum cardiomyopathy.
    Zhu J; Liu W
    BMC Cardiovasc Disord; 2021 Apr; 21(1):205. PubMed ID: 33888084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel marker of persistent left ventricular systolic dysfunction in patients with peripartum cardiomyopathy: monocyte count- to- HDL cholesterol ratio.
    Ekizler FA; Cay S
    BMC Cardiovasc Disord; 2019 May; 19(1):114. PubMed ID: 31092205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NT-proBNP and predictors of event free survival and left ventricular systolic function recovery in peripartum cardiomyopathy.
    Imran TF; Mohebali D; Lopez D; Goli RR; DeFilippis EM; Truong S; Bello NA; Gaziano JM; Djousse L; Coglianese EE; Feinberg L; Wu WC; Choudhary G; Arany Z; Kociol R; Sabe MA
    Int J Cardiol; 2022 Jun; 357():48-54. PubMed ID: 35358637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel score to predict left ventricular recovery in peripartum cardiomyopathy derived from the ESC EORP Peripartum Cardiomyopathy Registry.
    Jackson AM; Goland S; Farhan HA; Yaseen IF; Prameswari HS; Böhm M; Jhund PS; Maggioni AP; van der Meer P; Sliwa K; Bauersachs J; Petrie MC
    Eur Heart J; 2024 Apr; 45(16):1430-1439. PubMed ID: 38282532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular recovery in an African cohort of patients with peripartum cardiomyopathy.
    Dangwé Temoua N; Bamouni J; Mandi DG; Kaboré E; Allawaye L; Langtar MH; Adjougoulta A; Douné N; Adam A; Zakaria A; Rélwendé Aristide Y; Yibar K; Kologo KJ; Millogo GRC; Yaméogo NV; Zabsonré P
    Pan Afr Med J; 2024; 47():6. PubMed ID: 38371651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of various markers in recovery from peripartum cardiomyopathy: a systematic review and meta-analysis.
    Hosseinpour A; Hosseinpour H; Kheshti F; Abdollahifard S; Attar A
    ESC Heart Fail; 2022 Oct; 9(5):3483-3495. PubMed ID: 35883253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Clinical Characteristics and Outcomes of Peripartum Cardiomyopathy Between African American and Non-African American Women.
    Irizarry OC; Levine LD; Lewey J; Boyer T; Riis V; Elovitz MA; Arany Z
    JAMA Cardiol; 2017 Nov; 2(11):1256-1260. PubMed ID: 29049825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating T-Cell Subsets, Monocytes, and Natural Killer Cells in Peripartum Cardiomyopathy: Results From the Multicenter IPAC Study.
    McTiernan CF; Morel P; Cooper LT; Rajagopalan N; Thohan V; Zucker M; Boehmer J; Bozkurt B; Mather P; Thornton J; Ghali JK; Hanley-Yanez K; Fett J; Halder I; McNamara DM;
    J Card Fail; 2018 Jan; 24(1):33-42. PubMed ID: 29079307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of early and delayed recovery in peripartum cardiomyopathy: a prospective study of 52 Patients.
    Biteker M; Özlek B; Özlek E; Çil C; Çelik O; Doğan V; Başaran Ö
    J Matern Fetal Neonatal Med; 2020 Feb; 33(3):390-397. PubMed ID: 29945487
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.